Hawaii Oncology Inc-Kuakini
Honolulu, Hawaii, United States
Oncologist in Honolulu, Hawaii
321 N Kuakini St STE 412, Honolulu, HI 96817
About Hawaii Oncology Inc-Kuakini
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
SWOG Cancer Research Network
19
Alliance for Clinical Trials in Oncology
7
National Cancer Institute (NCI)
6
Gynecologic Oncology Group
2
Alliance Foundation Trials, LLC.
1
ECOG-ACRIN Cancer Research Group
1
NRG Oncology
1
Clinical Trials at Hawaii Oncology Inc-Kuakini
During the past decade, Hawaii Oncology Inc-Kuakini conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 31 clinical trials were completed, i.e. on
average, 310% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 18 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
2006-04-24
2021-09-01
Completed
1,943
Cixutumumab and Temsirolimus in Treating Patients With Locally Recurrent or Metastatic Breast Cancer
2008-10-31
2018-02-14
Completed
48
Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Stage I or Stage II Endometrial Cancer
2009-03-23
Unknown status
601
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
2011-11-01
2017-09-01
Completed
208
Everolimus With or Without Bevacizumab in Treating Patients With Advanced Kidney Cancer That Progressed After First-Line Therapy
2010-09-15
2017-12-16
Terminated
77
PROSPECT: Chemotherapy Alone or Chemotherapy Plus Radiation Therapy in Treating Patients With Locally Advanced Rectal Cancer Undergoing Surgery
2012-06-12
2023-06-30
Active, not recruiting
1,194
Gemcitabine Hydrochloride and Docetaxel Followed by Doxorubicin Hydrochloride or Observation in Treating Patients With High-Risk Uterine Leiomyosarcoma Previously Removed by Surgery
2012-06-04
2019-02-09
Terminated
38
S1202: Duloxetine Hydrochloride for Muscle/Joint Pain in Early-Stage Breast Cancer Receiving Hormone Therapy
2013-05-15
2018-12-20
Completed
299
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Hawaii Oncology Inc-Kuakini" #1 sponsor was "SWOG Cancer Research Network" with 19 trials, followed by "Alliance for Clinical Trials in Oncology" with 7 trials
sponsored, "National Cancer Institute (NCI)" with 6 trials sponsored, "Gynecologic Oncology Group" with 2 trials sponsored and "Alliance Foundation Trials, LLC."
with 2 trials sponsored. Other sponsors include -3 different institutions and
companies that sponsored additional 7 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Hawaii Oncology Inc-Kuakini"
#1 collaborator was "National Cancer Institute (NCI)" with 30 trials as a collaborator, "Daiichi Sankyo, Inc." with 2 trials as a collaborator, "Astellas Pharma US, Inc." with 1 trials as a collaborator, "Biologics, Inc." with 1 trials as a collaborator and "Canadian Cancer Trials Group" with 1 trials as a collaborator. Other collaborators include 3 different institutions and companies that were
collaborators in the rest 13 trials.
Clinical Trials Conditions at Hawaii Oncology Inc-Kuakini
According to Clinical.Site data, the most researched conditions in "Hawaii Oncology Inc-Kuakini" are
"Recurrent Squamous Cell Lung Carcinoma" (9 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (8 trials), "Breast Cancer" (3 trials), "Clear Cell Renal Cell Carcinoma" (2 trials) and "Colorectal Cancer" (2 trials). Many other conditions were trialed in "Hawaii Oncology Inc-Kuakini" in a lesser frequency.
Clinical Trials Intervention Types at Hawaii Oncology Inc-Kuakini
Most popular intervention types in "Hawaii Oncology Inc-Kuakini" are "Drug" (34 trials), "Other" (27 trials), "Biological" (11 trials), "Procedure" (3 trials) and "Radiation" (2 trials). Other intervention types were less common.
The name of intervention was led by "Laboratory Biomarker Analysis" (20 trials), "Docetaxel" (5 trials), "Quality-of-Life Assessment" (5 trials), "Pharmacological Study" (4 trials) and "Dexamethasone" (3 trials). Other intervention names were less common.
Clinical Trials Genders at Hawaii Oncology Inc-Kuakini
The vast majority of trials in "Hawaii Oncology Inc-Kuakini" are
30 trials for "All" genders, 5 trials for "Female" genders and 2 trials for "Male" genders.
Clinical Trials Status at Hawaii Oncology Inc-Kuakini
Currently, there are NaN active trials in "Hawaii Oncology Inc-Kuakini".
undefined are not yet recruiting,
1 are recruiting,
12 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 19 completed trials in Hawaii Oncology Inc-Kuakini,
undefined suspended trials,
and 4 terminated clinical trials to date.
Out of the total trials that were conducted in Hawaii Oncology Inc-Kuakini, 3 "Phase 1"
clinical trials were conducted, 22 "Phase 2" clinical
trials and 18 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 2 trials that are defined as “Not Applicable".